Related Experiment Video
Updated: Aug 15, 2026

Mimicking the Function of Signaling Proteins: Toward Artificial Signal Transduction Therapy
Published on: September 29, 2016
Signalling networks that cause cancer
1UCSF Cancer Center, Cancer Research Institute, 2340 Sutter St, San Francisco, CA 94115, USA. mccormick@cc.ucsf.edu
Abstract:
Cancer is caused by the stepwise accumulation of mutations that affect growth control, differentiation and survival. The view that mutations affect discrete signalling pathways, each contributing to a specific aspect of the full malignant phenotype, has proved to be too simplistic. We now know that oncogenes and tumour suppressors depend on one another for their selective advantage, and that they affect multiple pathways that intersect and overlap. The interactive nature of each genetic change has important implications for cancer therapy and for the stepwise model of carcinogenesis.
Insights
Cancer arises from accumulating mutations impacting cell growth and survival. These genetic changes interact across multiple pathways, challenging simple models and influencing cancer therapy strategies.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Cancer develops through the accumulation of genetic mutations affecting critical cellular processes like growth, differentiation, and survival.
- The traditional view of discrete signaling pathways being affected by specific mutations is an oversimplification of cancer development.
Purpose of the Study:
- To challenge the simplistic view of cancer development by highlighting the interactive nature of genetic mutations.
- To emphasize the interconnectedness of oncogenes and tumor suppressors in driving malignant phenotypes.
- To discuss the implications of these interactions for cancer therapy and the understanding of carcinogenesis.
Main Methods:
- Review and synthesis of current understanding of cancer genetics and molecular pathways.
- Analysis of the interplay between oncogenes and tumor suppressor genes.
- Conceptual framework development for understanding multi-pathway involvement in cancer.
Main Results:
- Genetic mutations in cancer do not act in isolation but influence multiple, overlapping signaling pathways.
- Oncogenes and tumor suppressors exhibit interdependence, with their selective advantages being mutually reinforcing.
- The complexity of genetic interactions within cancer cells is a key feature of the disease.
Conclusions:
- The interactive nature of genetic alterations is fundamental to cancer development.
- Understanding these complex interactions is crucial for developing effective, targeted cancer therapies.
- The stepwise model of carcinogenesis needs to incorporate the interconnectedness of genetic events.
Related Concept Videos
Autocrine Signaling
Autocrine Signaling in Macrophages
Under normal physiological conditions, autocrine signaling is essential for maintaining homeostasis. This process is well characterized in...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...

